124i-meta-iodobenzylguanidine
Small moleculeexperimentalImaging agent
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
4
Phase 3
1
Phase 4
0
Earliest trial started Dec 5, 2001 (NCT00028106)
Timeline
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 124-iodine
Oral
No
Parenteral
No
Topical
No
Also known as
- 124i-meta-iodobenzylguanidine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02071680 | Phase 3 | Mar 31, 2015 | University of Ottawa |
| NCT02043899 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2014 | Cancer Research UK |
| NCT01931488 | Phase 2 | Aug 31, 2013 | Tel Aviv University |
| NCT00028106 | Phase 2 | Dec 5, 2001 | National Institutes of Health (NIH) |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cancer Research UK | Academic/Hospital | 1 | 1 | 1 | 2014 |
| National Institutes of Health (NIH) | Government | 1 | 1 | 1 | 2001 |
| Tel Aviv University | Academic/Hospital | 1 | 1 | 1 | 2013 |
| University of Ottawa | Academic/Hospital | 1 | 1 | 1 | 2015 |
4 organizations
Page 1 / 1